CRTC Xtrackers US National Critical Technologies ETF

Expense Ratio
0.35%
Dividend
0.85%
Previous close
$40.66
Est. 12 months change
+17.17%
Projected Price
$47.64

Profitability Metrics

Return on Equity (ROE)
34.27%
Return on Assets (ROA)
10.46%
Return on Invested Capital (ROIC)
30.75%
Weighted Average Cost of Capital (WACC)
9.79%
ROIC - WACC
20.96%
Updated : 2026-08-05 21:01 ET

Valuation Metrics

P/E Ratio
24.55
Forward P/E
20.33
PEG Ratio
1.86
Debt Current Ratio
1.80

Growth & Cash Flow

Gross Margin
55.52%
Operating Margin
11.42%
FCF Margin
22.50%
TTM Revenue Growth
25.88%
Projected 12M EPS Growth
20.72%

Price Change

Price % from 50 SMA
4.52%
Price % from 200 SMA
8.63%
6 Months
12.88%
1 Year
17.07%
2 Years
42.40%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MSFT5.55%
GOOGL4.99%
AMZN4.73%
NVDA4.72%
META4.17%
AMD4.09%
XOM3.39%
ABBV2.36%
CSCO2.32%
CVX1.98%

ETF Analysis

Fund Overview

Xtrackers US National Critical Technologies ETF (CRTC) currently reports 173 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is MSFT (5.55%), GOOGL (4.99%), AMZN (4.73%), with MSFT as the largest single weight at 5.55%. Together, the top three holdings account for 15.27%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Profitability & Capital Efficiency

Examining the portfolio through a capital allocation lens, ROIC is 30.75%, WACC is 9.79%, and the economic spread is 20.96%. On balance, the spread between ROIC and WACC is solidly positive — reinvestment is adding value rather than diluting it. Supporting metrics show ROE at 34.27% and ROA at 10.46%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Valuation currently screens at trailing P/E of 24.55, forward P/E of 20.33, PEG of 1.86. Trailing and forward P/E are close together, implying the market does not expect a significant change in the earnings trajectory over the near term. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. The aggregate current ratio of 1.80 reflects a holding set with workable near-term liquidity positions. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

Margins & Cash Generation

From gross to free cash flow, gross margin sits at 55.52%, operating margin at 11.42%, and free cash flow margin at 22.50%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. Operating margins are thin enough to warrant attention — businesses at this level are more exposed to cost inflation. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.

Growth & Forward Outlook

Revenue momentum and analyst targets together paint a picture where the estimated 12-month price change of 17.34%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 25.88% reflecting top-line acceleration that, if sustained, supports the forward earnings case. Reported revenue growth is the operational foundation; the analyst target spread shows what the market is willing to pay above it — and that premium can evaporate quickly if delivery slips. For investors, the central question is whether the operating momentum visible in revenues is durable enough to support the price appreciation implied by consensus targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

When all the evidence is placed side by side, this profile stands out as one with genuine compounding characteristics and limited structural headwinds.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.